![]() |
MammaPrint genetic test can reduce use of post-surgery chemotherapy among early-stage
Among patients with early-stage breast cancer who were considered at high risk for disease recurrence based on clinical and biological criteria, the MammaPrint genetic test identified a large group...
More... |
| All times are GMT -7. The time now is 12:39 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021